ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,794.10
-0.43%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Soleno Therapeutics Inc (SLNO)

  7. Soleno Therapeutics Inc (SLNO) 뉴스

SLNO

Soleno Therapeutics (SLNO)

Soleno Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:SLNO
일자시간출처헤드라인심볼기업
2024/05/1521:00GlobeNewswire Inc.Soleno Therapeutics Stands with the Prader-Willi Syndrome CommunityNASDAQ:SLNOSoleno Therapeutics Inc
2024/05/1005:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLNOSoleno Therapeutics Inc
2024/05/1005:05GlobeNewswire Inc.Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:SLNOSoleno Therapeutics Inc
2024/05/0806:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLNOSoleno Therapeutics Inc
2024/05/0705:58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SLNOSoleno Therapeutics Inc
2024/05/0311:32GlobeNewswire Inc.Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common StockNASDAQ:SLNOSoleno Therapeutics Inc
2024/05/0305:01GlobeNewswire Inc.Soleno Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:SLNOSoleno Therapeutics Inc
2024/04/3021:00GlobeNewswire Inc.Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi SyndromeNASDAQ:SLNOSoleno Therapeutics Inc
2024/04/2921:00GlobeNewswire Inc.Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)NASDAQ:SLNOSoleno Therapeutics Inc
2024/04/2005:05GlobeNewswire Inc.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLNOSoleno Therapeutics Inc
2024/03/0906:05GlobeNewswire Inc.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLNOSoleno Therapeutics Inc
2024/03/0720:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLNOSoleno Therapeutics Inc
2024/03/0706:05GlobeNewswire Inc.Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:SLNOSoleno Therapeutics Inc
2024/02/2222:00GlobeNewswire Inc.Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:SLNOSoleno Therapeutics Inc
2024/02/0106:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/3106:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/3007:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/3007:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/3007:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/3006:05GlobeNewswire Inc.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLNOSoleno Therapeutics Inc
2024/01/2422:00GlobeNewswire Inc.Soleno Therapeutics Strengthens Leadership Team with Key AppointmentsNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/1806:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/0907:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/0907:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/0907:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/0606:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLNOSoleno Therapeutics Inc
2024/01/0522:00GlobeNewswire Inc.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLNOSoleno Therapeutics Inc
2024/01/0306:06Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:SLNOSoleno Therapeutics Inc
2023/12/1608:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
2023/12/1509:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
 검색 관련기사 보기:NASDAQ:SLNO

최근 히스토리

LVCN
AETETH
AeternumToken
AMEX
DMDV
Aam S&P Developed Market...
USOTC
APMFF
Eagle Graphite (CE)
NYSE
FIGS
FIGS
BMF
DAPQ24
DAPQ24 - Agosto 2024
BOV
VALEX805
VALEX805 Ex:77,83
ASX
ELTDA
Elementos
DGFX
NUUSDT
NuCypher
LSE
0DNS
Autostrade Meridionali
BIT
UR9KFW
UniCredit Bank
BIT
S28295
Societe Generale Effekten
NASDAQ
FVIHFX
Interest Rate Hedge Port...
CRTO
TUSDUSDT
TrueUSD
BIT
F18507
Vontobel Financial Produ...
GATE
TLOSUSDT
Telos
NASDAQ
JOYG
Joy Global
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유